Christopher Harker Hunt

Dr. Christopher Harker Hunt

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2012 in Muscle & Nerve
Verified
Journal Article
Closed access
PDF file
MCMichael S Cartwright
Michael S Cartwright
LHLisa D Hobson-Webb
Lisa D Hobson-Webb
ABAndrea J Boon
Andrea J Boon
KAKatharine E Alter
Katharine E Alter
CHChristopher Harker Hunt
Christopher Harker Hunt
AMAmerican Association of Neuromuscular and Electrodiagnostic Medicine
American Association of Neuromuscular and Electrodiagnostic Medicine

1 October 2009 in American Journal of Roentgenology
Verified
Journal Article
Closed access
CHChristopher Harker Hunt
Christopher Harker Hunt
RHRobert P. Hartman
Robert P. Hartman
GHGina K. Hesley
Gina K. Hesley
OBJECTIVE. The purpose of this study was to determine the frequency and characteristics of adverse effects of low-osmolar iodinated and gadolinium contrast agents in a single-center experience with a large number of cases.MATERIALS AND METHODS. A retrospective review of all intravascular doses of low-osmolar iodinated and gadolinium contrast materials administered from 2002 through 2006 was conducted. Adverse effects were identified through the use of radiologist and nurse event recording. Adverse effects were examined for type and severity of reaction, treatment required, and outcome.RESULTS. A total of 456,930 contrast doses (298,491 low-osmolar iodinated, 158,439 gadolinium) were administered over the study period. A total of 522 cases of adverse effects (0.11% of total) were identified (458 low-osmolar iodinated, 64 gadolinium). The most common adverse effects were hives (274, 52.5%) and nausea (92, 17.6%). Of all adverse effects, 79 of low-osmolar iodinated and 15 of gadolinium contrast material nece...

15 December 2011 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
JAJ.J. Akbar
J.J. Akbar
PLP.H. Luetmer
P.H. Luetmer
KSK.M. Schwartz
K.M. Schwartz
CHChristopher Harker Hunt
Christopher Harker Hunt
FDF.E. Diehn
F.E. Diehn
LEL.J. Eckel
L.J. Eckel
BACKGROUND AND PURPOSE: Localization of spinal CSF leaks in CSF hypovolemia is critical in directing focal therapy. In this retrospective review, our aim was to determine whether GdM was helpful in confirming and localizing spinal CSF leaks in patients in whom no leak was identified on a prior CTM. MATERIALS AND METHODS: Forty-one symptomatic patients with clinical suspicion of SIH were referred for GdM after undergoing at least 1 CTM between February 2002 and August 2010. A retrospective review of the imaging and electronic medical records was performed on each patient. RESULTS: In 17 of the 41 patients (41%), GdM was performed for follow-up of a previously documented leak at CTM. In the remaining 24 patients (59%), in whom GdM was performed for a suspected CSF leak, which was not identified on CTM, GdM localized the CSF leak in 5 of 24 patients (21%). In 1 of these 5 patients, GdM detected the site of leak despite negative findings on brain MR imaging, spine MR imaging, and CTM of the entire spine. Sixteen of 17 patients with previously identified leaks underwent interval treatment, and leaks were again identified in 12 of 17 (71%). CONCLUSIONS: GdM is a useful technique in the highly select group of patients who have debilitating symptoms of SIH, a high clinical index of suspicion of spinal CSF leak, and no demonstrated leak on conventional CTM. Intrathecal injection of gadolinium contrast remains an off-label use and should be reserved for those patients who fail conventional CTM.

22 December 2011 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
PLP.H. Luetmer
P.H. Luetmer
KSK.M. Schwartz
K.M. Schwartz
LEL.J. Eckel
L.J. Eckel
CHChristopher Harker Hunt
Christopher Harker Hunt
RCR.E. Carter
R.E. Carter
FDF.E. Diehn
F.E. Diehn
BACKGROUND AND PURPOSE: Some patients with SIH have fast CSF leaks requiring dynamic CTM for localization; however, patients generally undergo conventional CTM before a dynamic study. Our aim was to determine whether findings on head MR imaging, spine MR imaging, or opening pressure measurements can predict fast spinal CSF leaks. MATERIALS AND METHODS: A retrospective review was performed on 151 consecutive patients referred for CTM to evaluate for spinal CSF leak. Head MR imaging was evaluated for diffuse dural enhancement and “brain sag,” and spine MR imaging for presence of an extradural fluid collection. The opening pressure was recorded. The CTM was scored as no leak, slow leak localized on conventional CTM, or fast leak that required dynamic CTM. RESULTS: Fast CSF leaks were identified in 32 (21%), slow leaks in 36 (24%), and no leak in 83 (55%) of 151 patients on initial CTM. There was significant association between spinal extra-arachnoid fluid on MR imaging and the presence of a fast leak (sensitivity 85%, specificity 79%, P < .0001). There was not significant association between fast leak and findings on head MR imaging (P = .27) or opening pressure (P = .30). CONCLUSIONS: If all patients with spinal extra-arachnoid CSF on MR imaging had been sent directly to dynamic CTM, repeat myelography would have been avoided in most patients with fast leaks (23 of 27; 85%). However, a minority of patients with slow or no leaks would have been converted from conventional to dynamic CTM (16 of 77; 21%). Spinal MR imaging is helpful in premyelographic evaluation of SIH.

1 September 2019 in Radiology
Verified
Journal Article
Closed access
JMJennifer S. McDonald
Jennifer S. McDonald
CHChristopher Harker Hunt
Christopher Harker Hunt
AKAmy B. Kolbe
Amy B. Kolbe
JSJohn Joseph Schmitz
John Joseph Schmitz
RHRobert P. Hartman
Robert P. Hartman
RMRobert J. McDonald
Robert J. McDonald
The rate of acute reactions following gadolinium-based contrast agent administration is affected by type of contrast agent used and patient demographics. Background Acute allergic-like and physiologic reactions occur following administration of gadolinium-based contrast agents (GBCAs) for MRI examinations. Because these reactions are uncommon, it is...

22 October 2020 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
AMA.A. Madhavan
A.A. Madhavan
CCC.M. Carr
C.M. Carr
PMP.P. Morris
P.P. Morris
EFE.P. Flanagan
E.P. Flanagan
AKA.L. Kotsenas
A.L. Kotsenas
FDF.E. Diehn
F.E. Diehn
Paraneoplastic syndromes are systemic reactions to neoplasms mediated by immunologic or hormonal mechanisms. The most well-recognized paraneoplastic neurologic syndrome, both clinically and on imaging, is limbic encephalitis. However, numerous additional clinically described syndromes affect the brain, spinal cord, and peripheral nerves. Many of these syndromes can have imaging findings that, though less well described, are important in making the correct diagnosis. Moreover, imaging in these syndromes frequently mimics more common pathology, which can be a diagnostic challenge for radiologists. Our goal is to review the imaging findings of paraneoplastic neurologic syndromes, including less well-known entities and atypical presentations of common entities. Specifically, we discuss limbic encephalitis, paraneoplastic cerebellar degeneration, paraneoplastic brain stem encephalitis, cranial neuropathy, myelitis, and polyneuropathy. We also demonstrate common diagnostic pitfalls that can be encountered when imaging these patients.